Citius Pharmaceuticals is trading at $0.61 (+5.67%) after the August 26, 2026 close, with the move appearing aligned with broader market strength.
- The S&P 500 rose 0.64%, while the Nasdaq Composite gained 0.68% during the session.
- Fiscal third-quarter results released August 14 are recent company news, but not a fresh catalyst for this after-hours move.
- No newly identified company-specific announcement was reported.